Putting the award page together from the records…
Putting the award page together from the records…
Joint Medical Store received this contract from Usaid/Uganda, Agency for International Development: $57.86M obligated so far for support- professional: program management/support. Its period of performance ended 2026-09-30.
Key facts · data as of Oct 23, 2026
Source: USAspending.gov prime award records (obligations: money committed, not outlays), data as of Oct 23, 2026.
Cite this page: SpendQuery, Award 72061723F00003, data as of Oct 23, 2026, https://spendquery.com/award?id=CONT_AWD_72061723F00003_7200_72061721D00002_7200
Joint Medical Store: all federal awards · Agency for International Development: spending · Usaid/Uganda: what it buys · The follow-on: recompete brief
THE PURPOSE OF THIS TASK ORDER IS TO PROCURE AND DELIVER A RANGE OF HIV COMMODITIES NAMELY ANTIRETROVIRAL (ARV) CO-TRIMOXAZOLE HIV/SYPHILIS DUO, 25 TESTS (E.G. SD BIOLINE) HIV RAPID RECENCY ASSAY, BULK FORMAT, 100 TESTS/KIT (E.G., ASANTE) AND CRAG
Up for re-bid: ends 2026-09-30. Recompete brief →
SpendQuery holds FY2023 on; earlier years are on USAspending.gov.
No subawards reported for this award. Primes report subawards of $30,000 or more; many awards have none.
8 actions since 2023-05-12. Each is a modification or amendment with the money it added or took back.
| Date | Modification | Kind | Amount | What the agency wrote |
|---|---|---|---|---|
| 2026-06-24 | P00007 | Funding only | $2.66M | THE PURPOSE OF THIS MODIFICATION IS TO: 1) PROVIDE 2,661,908 IN INCREMENTAL FUNDS FOR THE CONTINUED SUPPORT OF THE SUBJECT ACTIVITY |
| 2026-05-12 | P00006 | Additional work (new agreement) | $1.54M | THE PURPOSE OF THIS MODIFICATION IS TO: 1) PROVIDE 1,540,962.00 IN INCREMENTAL FUNDS FOR THE CONTINUED SUPPORT OF THE SUBJECT ACTIVITY AND 2) EXTEND THE PERIOD OF PERFORMANCE TO 09/30/2026 |
| 2026-02-20 | P00005 | Funding only | $3.00M | THE PURPOSE OF THIS MODIFICATION IS TO: 1) PROVIDE $3,000,000 IN INCREMENTAL FUNDS FOR THE CONTINUED SUPPORT OF THE SUBJECT ACTIVITY |
| 2024-09-26 | P00004 | Funding only | $9.57M | THE PURPOSE OF THIS MODIFICATION IS TO: 1) PROVIDE $9,571,849.00 IN INCREMENTAL FUNDS FOR THE CONTINUED SUPPORT OF THE SUBJECT ACTIVITY THEREBY INCREASING THE TOTAL OBLIGATED AMOUNT TO DATE FROM $41,082,671.01 TO $50,654,520.01 2) UPDATE THE PART I |
| 2024-03-19 | P00003 | Funding only | $3.18M | THE PURPOSE OF THIS MODIFICATION IS TO: 1) PROVIDE $3,183,114.00 IN INCREMENTAL FUNDS FOR THE CONTINUED SUPPORT OF THE SUBJECT ACTIVITY THEREBY INCREASING THE TOTAL OBLIGATED AMOUNT TO DATE FROM $37,899,557.0 TO $41,082,671.0. 2) UPDATE THE PART I |
| 2023-12-05 | P00002 | Funding only | $10.48M | JMS MEGARFTOP: THE PURPOSE OF THIS MODIFICATION IS TO INCREMENTALLY FUND THE ACTIVITY WITH $ 10,479, 821 THEREBY INCREASING THE TOTAL OBLIGATED AMOUNT FROM $ 27,419,736.01 TO $ 37,899,557.01 |
| 2023-11-22 | P00001 | Funding only | $6.91M | THE PURPOSE OF THIS MODIFICATION IS TO: 1) DECREASE THE TOTAL ESTIMATED COST (TEC) BY $2,600,000.00 FROM $118,067,242.00 TO $115,467,242.00. 2) PROVIDE $6,905,924.00 IN INCREMENTAL FUNDS FOR THE CONTINUED SUPPORT OF THE SUBJECT ACTIVITY THEREBY INC |
| 2023-05-12 | 0 | $20.51M | THE PURPOSE OF THIS TASK ORDER IS TO PROCURE AND DELIVER A RANGE OF HIV COMMODITIES NAMELY ANTIRETROVIRAL (ARV) CO-TRIMOXAZOLE HIV/SYPHILIS DUO, 25 TESTS (E.G. SD BIOLINE) HIV RAPID RECENCY ASSAY, BULK FORMAT, 100 TESTS/KIT (E.G., ASANTE) AND CRAG |
Source: USAspending.gov prime award transactions and FSRS subaward reports, as loaded by SpendQuery (data as of 2026-10-23). Amounts are obligations (money committed), not outlays. The official record on USAspending.gov ↗